CellBion Co., Ltd. (KOSDAQ: A308430)
Health Care · Pharmaceuticals · KR
₩13,000.00
+1.64% today · -54.2% 1Y
CellBion Co., Ltd. (KOSDAQ: A308430) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $121.25M.
Over the last twelve months the share price has lost 54.2%, trading between 9.93K and 42.20K.
Tweenvest scores CellBion Co., Ltd. across four factors: quality 31/100, value 36/100, growth 0/100. Its strongest factor is value.
A308430 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $121.25M
- Revenue (TTM)
- $1.39M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩42,200.00
- 52-week low
- ₩9,930.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.91M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.50 | -0.03% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.50 | -0.56% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.74 | +0.05% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.10 | +0.19% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.32 | +0.18% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.